IGF-1 LR3
Mixed evidenceEngineered to escape the body's natural brakes on a growth signal, it builds muscle while raising one of the cleanest cancer-risk flags in epidemiology.
What it is
IGF-1 LR3 is a modified version of insulin-like growth factor-1, a natural hormone that tells tissues to grow. A chemical edit lets it slip free of the binding proteins that normally keep most natural IGF-1 locked up, so it circulates unbound and highly active. It was originally made as a lab reagent for growing cells.
How it works
In the body, natural IGF-1 is mostly held in a buffering complex that keeps its growth signal controlled and pulsing. LR3 dodges that buffer, so it stays free and active, and with daily dosing the growth signal stays steadily elevated, bypassing the natural ceiling on tissue growth and pushing muscle, repair, and fat breakdown.
What people report
- ✦Genuine anabolic effect; users report visible muscle growth
- ✦Promotes tissue repair and fat loss alongside the muscle signal
- ✦Free, unbuffered signaling is far more sustained than the body's own pulses
- ✦Widely available from research suppliers
Typical use
Typically injected daily during a muscle-building phase. Its own half-life is short, roughly one to two hours; the repeated '20–30 hour' figure floating around is a myth.
Dosing reference
No approved dose and no human pharmacokinetic data. The sustained effect comes from daily dosing, not from a long half-life. Verify any product and schedule, because the acute blood-sugar risk from cross-reacting with the insulin receptor is real.
Reference only — not a recommendation. Verify via primary sources.
Watch for
This is the serious one. Chronic elevation of free IGF-1 is one of the most consistent cancer-risk signals in population research, tied to prostate and other cancers, while people who genetically lack it show strikingly low cancer rates. This molecule was engineered specifically to defeat the regulatory system evolution built to keep that signal controlled.
Notes
The muscle-growth benefit is supported. So is the cancer-risk concern, by decades of epidemiology. Casual physique use is a bad trade.
Educational content — not medical advice.